1620 Investment Advisors Inc. Boosts Stake in HealthEquity, Inc. (NASDAQ:HQY)

1620 Investment Advisors Inc. increased its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 44.4% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,973 shares of the company’s stock after purchasing an additional 607 shares during the quarter. 1620 Investment Advisors Inc.’s holdings in HealthEquity were worth $189,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently made changes to their positions in the stock. Holocene Advisors LP acquired a new stake in HealthEquity during the third quarter worth about $1,246,000. Loomis Sayles & Co. L P lifted its holdings in HealthEquity by 2.2% during the 3rd quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company’s stock worth $92,216,000 after buying an additional 24,665 shares during the last quarter. Geneva Capital Management LLC lifted its holdings in shares of HealthEquity by 24.6% in the 4th quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company’s stock worth $100,642,000 after purchasing an additional 206,894 shares during the last quarter. BNP Paribas Financial Markets lifted its holdings in shares of HealthEquity by 165.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 20,437 shares of the company’s stock worth $1,673,000 after purchasing an additional 12,745 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of HealthEquity by 2.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company’s stock worth $104,280,000 after purchasing an additional 25,004 shares during the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Stock Up 0.3 %

HealthEquity stock opened at $84.60 on Friday. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59. The company’s 50-day moving average price is $105.20 and its two-hundred day moving average price is $95.51. The stock has a market cap of $7.33 billion, a P/E ratio of 77.61, a P/E/G ratio of 1.60 and a beta of 0.62. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. Barrington Research restated an “outperform” rating and issued a $112.00 target price on shares of HealthEquity in a research report on Friday, March 14th. Mizuho assumed coverage on HealthEquity in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price for the company. Wells Fargo & Company lifted their price objective on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research report on Wednesday, February 26th. JMP Securities boosted their price target on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday, December 10th. Finally, Royal Bank of Canada lifted their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. One analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and a consensus price target of $112.92.

Insider Transactions at HealthEquity

In other news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 2.20% of the stock is owned by company insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.